 Charanjeet Singh
Concepts (50)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Cholangiocarcinoma | 2 | 2025 | 108 | 0.980 |
Why?
| | Bile Duct Neoplasms | 2 | 2025 | 131 | 0.960 |
Why?
| | Calcaneus | 1 | 2016 | 31 | 0.460 |
Why?
| | Positron-Emission Tomography | 1 | 2016 | 343 | 0.410 |
Why?
| | Bone Neoplasms | 1 | 2016 | 265 | 0.390 |
Why?
| | Pain | 1 | 2016 | 791 | 0.310 |
Why?
| | Adenocarcinoma | 1 | 2016 | 926 | 0.280 |
Why?
| | Tomography, X-Ray Computed | 3 | 2025 | 2770 | 0.280 |
Why?
| | Biomarkers, Tumor | 2 | 2026 | 1329 | 0.230 |
Why?
| | Tracheal Stenosis | 1 | 2006 | 39 | 0.230 |
Why?
| | Aortic Diseases | 1 | 2006 | 125 | 0.210 |
Why?
| | Bile Ducts, Intrahepatic | 1 | 2024 | 63 | 0.210 |
Why?
| | Diagnosis, Differential | 2 | 2024 | 1512 | 0.200 |
Why?
| | Endometrial Neoplasms | 1 | 2026 | 205 | 0.200 |
Why?
| | Aorta, Thoracic | 1 | 2006 | 286 | 0.190 |
Why?
| | Dyslipidemias | 1 | 2024 | 184 | 0.190 |
Why?
| | Cholesterol, LDL | 1 | 2024 | 360 | 0.180 |
Why?
| | Lung Neoplasms | 1 | 2016 | 2667 | 0.180 |
Why?
| | Magnetic Resonance Imaging | 2 | 2025 | 3915 | 0.140 |
Why?
| | Cystadenocarcinoma, Serous | 1 | 2019 | 89 | 0.130 |
Why?
| | Cadherins | 1 | 2019 | 200 | 0.130 |
Why?
| | Practice Patterns, Physicians' | 1 | 2026 | 1372 | 0.120 |
Why?
| | Technetium Tc 99m Medronate | 1 | 2016 | 5 | 0.120 |
Why?
| | Antigens, CD | 1 | 2019 | 558 | 0.110 |
Why?
| | Radiopharmaceuticals | 1 | 2016 | 205 | 0.110 |
Why?
| | Multimodal Imaging | 1 | 2016 | 129 | 0.110 |
Why?
| | Risk Factors | 2 | 2024 | 10917 | 0.100 |
Why?
| | Ovarian Neoplasms | 1 | 2019 | 595 | 0.090 |
Why?
| | Cardiovascular Diseases | 1 | 2024 | 2191 | 0.090 |
Why?
| | Immunohistochemistry | 2 | 2026 | 1723 | 0.070 |
Why?
| | Humans | 7 | 2026 | 145763 | 0.060 |
Why?
| | Asia | 1 | 2026 | 70 | 0.060 |
Why?
| | Pathologists | 1 | 2026 | 19 | 0.060 |
Why?
| | Bile Ducts, Extrahepatic | 1 | 2025 | 20 | 0.060 |
Why?
| | North America | 1 | 2026 | 303 | 0.050 |
Why?
| | Europe | 1 | 2026 | 421 | 0.050 |
Why?
| | India | 1 | 2024 | 213 | 0.050 |
Why?
| | Prognosis | 2 | 2026 | 4329 | 0.050 |
Why?
| | Neoplasm Staging | 1 | 2026 | 1474 | 0.040 |
Why?
| | Female | 4 | 2026 | 79035 | 0.040 |
Why?
| | Ribonucleoproteins, Small Nucleolar | 1 | 2019 | 5 | 0.040 |
Why?
| | Neoplasm Grading | 1 | 2019 | 311 | 0.030 |
Why?
| | Neoplasm Invasiveness | 1 | 2019 | 508 | 0.030 |
Why?
| | Ovary | 1 | 2019 | 234 | 0.030 |
Why?
| | Practice Guidelines as Topic | 1 | 2024 | 1582 | 0.030 |
Why?
| | Kaplan-Meier Estimate | 1 | 2019 | 971 | 0.030 |
Why?
| | Middle Aged | 1 | 2016 | 36302 | 0.020 |
Why?
| | Surveys and Questionnaires | 1 | 2026 | 6085 | 0.020 |
Why?
| | Neoplasm Recurrence, Local | 1 | 2019 | 1150 | 0.020 |
Why?
| | Child, Preschool | 1 | 2006 | 11868 | 0.020 |
Why?
|
|
Singh's Networks
Click the "See All" links for more information and interactive visualizations!
Concepts  Derived automatically from this person's publications. _
Co-Authors People in Profiles who have published with this person. _
Similar People People who share similar concepts with this person. _
Same Department
People who are also in this person's primary department.
|